Author of

• 31780

  +

  P2.17 - Treatment of Early Stage/Localized Disease (ID 189)

  • Event: WCLC 2019
  • Type: Poster Viewing in the Exhibit Hall
  • Track: Treatment of Early Stage/Localized Disease
  • Presentations: 1
  • Now Available
  • Moderators:
  • Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall

  • 31830

    +

    P2.17-43 - Complete Uniportal Thoracoscopic Anatomic Lung Resection with Systematic Mediastinal Lymphadenectomy for NSCLC (Now Available) (ID 899)

    10:15 - 18:15  |  Author(s): Zhe Wang
    • Abstract
    • Slides

    Background
    

    With its growing popularity and potential outcome, complete uniportal thoracoscopic surgery has been used in the treatment of thoracic diseases. This study aimed to summarize a personal experience of complete uniportal thoracoscopic anatomic lung resection with systematic mediastinal lymphadenectomy (CUT–ALR–SML) for non-small cell lung cancer (NSCLC) and to evaluate the feasibility and safety of CUT–ALR–SML in our institute.

    Method
    

    A total of 326 patients with NSCLC were chosen to undergo CUT–ALR–SML in our institute from August 2013 to July 2018. Data such as clinicopathologic characteristics and perioperative outcomes were restrospectively reviewed in this article.

    Result
    

    For the 326 cases of anatomic lung resection, the specific procedures and corresponding number of cases were as follows: segmentectomy, 90; lobectomy, 218; sleeve lobectomy, 9; ipsilateral lobe combined with segment resected synchronously (i-L+S), 6; and pneumonectomy, 3. A total of 31 cases required conversion to open surgery, and 4 cases were converted to multiportal thoracoscopic surgery. All patients underwent systematic mediastinal lymphadenectomy. The average mediastinal lymph node stations and mediastinal lymph nodes dissected under CUT–ALR–SML was 3.3±1.4 and 9.6±8.4,respectively. Approximately 99.7% of the patients acquired free resection margins. A total of 42 (12.9%) patients suffered from postoperative complications, and 1 patient died of pneumonia during the perioperative period.

    Conclusion
    

    Complete uniportal anatomic lung resection, particularly for segmentectomy and lobectomy is safe and feasible with low complication rates, and excellent free resection margin rates. Systematic mediastinal lymphadenectomy during complete uniportal thoracoscopic surgery adequately assesses the N2 lymph node. However, further studies need to be conducted to evaluate the role of CUT–ALR–SML in the treatment of NSCLC.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.